期刊
FRONTIERS IN HUMAN NEUROSCIENCE
卷 14, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fnhum.2020.595567
关键词
mental health; neuropsychiatric; TMS; COVID-19; tDCS; TES; NEUROCOVID
资金
- Lourie Foundation, Inc.
- National Institutes of Health [R21NS101712-01, R01NS101362, R01NS095123, R01NS112996, R01MH111896, R01MH109289]
- United States Department of Defense [W81XWH-17-1-0320]
- National Multiple Sclerosis Society [RG-1803-30492]
- Department of Veterans Affairs [1IK6RX003075]
- NIH [P2C HD086844, P20 GM109040, U54 GM104941]
- CNPq/Brazil level 2 scholarships for productivity in science
- CEPID/BRAINN -The Brazilian Institute of Neuroscience and Neurotechnology [13/07559-3]
The coronavirus disease 19 (COVID-19) pandemic has resulted in the urgent need to develop and deploy treatment approaches that can minimize mortality and morbidity. As infection, resulting illness, and the often prolonged recovery period continue to be characterized, therapeutic roles for transcranial electrical stimulation (tES) have emerged as promising non-pharmacological interventions. tES techniques have established therapeutic potential for managing a range of conditions relevant to COVID-19 illness and recovery, and may further be relevant for the general management of increased mental health problems during this time. Furthermore, these tES techniques can be inexpensive, portable, and allow for trained self-administration. Here, we summarize the rationale for using tES techniques, specifically transcranial Direct Current Stimulation (tDCS), across the COVID-19 clinical course, and index ongoing efforts to evaluate the inclusion of tES optimal clinical care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据